Renal cancer response to rapamycin analog CCI-779 treatment: time course

Download

Expression profiling of peripheral blood mononuclear cells (PBMC) from patients with advanced renal cancer following treatment with the rapamycin analog CCI-779. Gene expression examined 8 and 16 weeks after treatment. Results identify potential gene markers of CCI-779 exposure.

Cancer Type: renal cancer

GPL: 8300

Number of Genes with Data: 813

Number Observations: 79

Number Outputs: 1

Imbalanced Ratio: 0.6

Default Task: Classification